The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years
Title:
The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years
Author:
Loglio, A. Galmozzi, E. Iavarone, M. Facchetti, F. ViganĂ², M. Perbellini, R. Segato, S. Filippi, E. Rumi, M.G. Sangiovanni, A. Lampertico, P.